Anthony Vendetti

Jeff Cohen

Jonathan Aschoff

Nicholas Sherwood

- Helius Medical Technologies, Inc. (HSDT) has changed its corporate name to **Solana Company**, effective **September 29, 2025**, while retaining its **HSDT ticker symbol**.  **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex3-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_8k.htm:1]** 
- The company entered into a **non-binding letter of intent with the Solana Foundation**, committing to "Solana By Design" terms, which include conducting all on-chain activity solely on Solana (SOL) and engaging in joint initiatives.  **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_8k.htm:2]** 
- HSDT will have the option to **purchase SOL tokens from the Solana Foundation at a discount** and continues its digital asset treasury strategy, utilizing cash from a recent **$500 million PIPE financing**.  **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]** **[1610853_0001104659-25-094134_tm2527115d1_ex99-1.htm:0]**

Helius Medical Technologies, Inc. Announces Name Change to Solana Company and Letter of Intent with Solana Foundation

- **Helius Medical Technologies, Inc. (HSDT)** has officially changed its corporate name to **Solana Company**, with its ticker symbol **HSDT** remaining unchanged.  **[1610853_01427ccf50e94a7ea70778bc6c379a37_0]** 
- The company has entered into a non-binding letter of intent with the **Solana Foundation**, committing to "Solana By Design" terms, which include conducting all on-chain activity solely on Solana and participating in joint initiatives.  **[1610853_01427ccf50e94a7ea70778bc6c379a37_0]** 
- **Solana Company** will continue its digital asset treasury strategy of accumulating **SOL tokens**, intending to use cash from its recent **$500 million PIPE financing** for this purpose.  **[1610853_01427ccf50e94a7ea70778bc6c379a37_0]** 
- The company's mission is to maximize **SOL per share** and deliver consistent on-chain yield for investors, aiming to accelerate the growth of Solana.  **[1610853_01427ccf50e94a7ea70778bc6c379a37_0]**

HSDT Changes Name to Solana Company and Enters Agreement with Solana Foundation

- Helius Medical Technologies, Inc. (HSDT) has filed a **U.S. Food and Drug Administration (FDA) 510(k) submission** for the PoNS device label expansion, seeking an indication for **gait and balance deficit in patients with chronic stroke symptoms**.  **[1610853_0001104659-25-093161_hsdt-20250924xex99d1.htm:0]** **[1610853_0001104659-25-093161_hsdt-20250924x8k.htm:2]** 
- The submission is supported by data from the Stroke Registrational Program, which demonstrated the **superior effectiveness** of PoNS Therapy in improving gait deficit, achieving a statistically significant mean improvement of **5.37 points** in the Functional Gait Assessment (FGA) for the active treatment group compared to **3.31 points** for the control group.  **[1610853_0001104659-25-093161_hsdt-20250924xex99d1.htm:0]** 
- This filing was made under the company's existing **FDA Breakthrough Device Designation**.  **[1610853_0001104659-25-093161_hsdt-20250924xex99d1.htm:0]** **[1610853_0001104659-25-093161_hsdt-20250924x8k.htm:2]** 
- The company also entered into side letter agreements with its President and CEO, Dane C. Andreeff, and CFO, Jeffrey S. Mathiesen, providing **one-time discretionary cash bonuses** of **$890,000** and **$610,000**, respectively, in exchange for waiving certain change-in-control rights related to recent securities offerings.  **[1610853_0001104659-25-093161_hsdt-20250924x8k.htm:1]** **[1610853_0001104659-25-093161_hsdt-20250924xex10d1.htm:1]** **[1610853_0001104659-25-093161_hsdt-20250924xex10d2.htm:1]**

Helius Medical Technologies Files FDA 510(k) Submission for PoNS Device in Stroke and Announces Executive Bonuses

- Helius Medical Technologies, Inc. (HSDT) announced the initiation of its digital asset treasury strategy, with **Solana (SOL)** tokens as the principal holding.  **[1610853_0001104659-25-091854_tm2526642d1_ex99-1.htm:0]** 
- The company has acquired **over 760,190 SOL** at an average cost basis of **$231**.  **[1610853_0001104659-25-091854_tm2526642d1_ex99-1.htm:0]** 
- HSDT also holds **over $335 million in cash** designated for further digital asset treasury investments.  **[1610853_0001104659-25-091854_tm2526642d1_ex99-1.htm:0]** 
- This strategy aims to support tokenized network growth and security through long-term SOL holdings, complementing its neurotech and medical device operations.  **[1610853_0001104659-25-091854_tm2526642d1_ex99-1.htm:0]**

Helius Medical Technologies Initiates Solana (SOL) Digital Asset Treasury Strategy

- Helius Medical Technologies, Inc. closed a private placement offering on **September 18, 2025**, raising over **$500 million** in gross proceeds, with potential total proceeds exceeding **$1.25 billion** upon full warrant exercise.  **[1610853_0001104659-25-091281_tm2526455d1_ex99-1.htm:0]** **[1610853_0001104659-25-091281_tm2526455d1_8k.htm:1]** **[1610853_0001104659-25-091281_tm2526455d1_8k.htm:7]** 
- The company will use the net proceeds to implement a new digital asset treasury strategy, acquiring **SOL**, the native cryptocurrency of the Solana blockchain, as its primary treasury reserve asset.  **[1610853_0001104659-25-091281_tm2526455d1_ex99-1.htm:0]** **[1610853_0001104659-25-091281_tm2526455d1_8k.htm:2]** 
- In connection with the offering, **Joseph Chee** (Founder and Chairman of Summer Capital) was appointed **Executive Chairman and Director**, and **Cosmo Jiang** (General Partner at Pantera Capital) was appointed as a **board observer**.  **[1610853_0001104659-25-091281_tm2526455d1_ex99-1.htm:0]** **[1610853_0001104659-25-091281_tm2526455d1_8k.htm:5]** 
- The company also increased its authorized shares of Class A Common Stock to **800,000,000** shares, effective **September 15, 2025**, to support its new strategic direction.  **[1610853_0001104659-25-091281_tm2526455d1_ex3-1.htm:0]** **[1610853_0001104659-25-091281_tm2526455d1_8k.htm:7]**

Helius Medical Technologies Secures Over $500M in Private Placement to Fund Solana Treasury Strategy

- Helius Medical Technologies (Nasdaq: HSDT) closed a private placement offering, generating **over $500 million** in gross proceeds, with an additional **$750 million** potentially available from warrant exercises, totaling **over $1.25 billion** in potential proceeds.  **[1610853_20250918SF77375:0]** 
- The company intends to use the net proceeds to implement a digital asset treasury strategy and acquire **SOL**, the native cryptocurrency of the Solana blockchain, which will serve as its primary treasury reserve asset.  **[1610853_20250918SF77375:0]** 
- The offering was led by **Pantera Capital** and **Summer Capital**, and Helius appointed **Joseph Chee** as Executive Chairman and Director, **Cosmo Jiang** as a board observer, and **Dan Morehead** as a Strategic Advisor.  **[1610853_20250918SF77375:0]** 
- Helius plans to build an initial SOL position and significantly scale holdings over the next **12-24 months**, evaluating staking and lending opportunities to generate revenue from the SOL Treasury.  **[1610853_20250918SF77375:1]**

Helius Medical Technologies Closes Private Placement to Launch SOL Treasury Company

- **Helius Medical Technologies, Inc.** entered into a **Sales Agreement** on **September 15, 2025**, with **Clear Street LLC** and **Maxim Group LLC** to sell up to **$92.8 million** of its Class A common stock.  **[1610853_0001104659-25-089778_tm2526081d1_ex1-1.htm:0]** **[1610853_0001104659-25-089778_tm2526081d1_8k.htm:1]** **[1610853_0001104659-25-089778_tm2526081d1_ex5-1.htm:1]** 
- Under this agreement, the company will pay the agents a commission of up to **3.00%** of the aggregate gross proceeds from these sales.  **[1610853_0001104659-25-089778_tm2526081d1_8k.htm:1]** 
- This offering follows the termination of a previous sales agreement with Roth Capital Partners, LLC, dated June 23, 2023.  **[1610853_0001104659-25-089778_tm2526081d1_8k.htm:1]** 
- Stockholders approved an increase in the number of authorized shares of Common Stock to up to **800,000,000** shares on May 23, 2025, enabling this offering.  **[1610853_0001104659-25-089778_tm2526081d1_8k.htm:2]**

Helius Medical Technologies enters Sales Agreement for up to $92.8 million stock offering

- Helius Medical Technologies, Inc. (HSDT) announced an oversubscribed private investment in public equity (PIPE) offering, raising **over $500 million** to launch a SOL Treasury Company.  **[1610853_0001104659-25-089774_tm2526070d1_ex99-1.htm:0]** **[1610853_0001104659-25-089774_tm2526070d1_ex99-1.htm:2]** 
- The company intends to use the net proceeds to acquire **SOL**, the native cryptocurrency of the Solana blockchain, to serve as its primary treasury reserve asset.  **[1610853_0001104659-25-089774_tm2526070d1_ex99-1.htm:0]** **[1610853_0001104659-25-089774_tm2526070d1_ex99-1.htm:2]** 
- The offering, expected to close around **September 18, 2025**, is led by Pantera Capital and Summer Capital, with participation from other prominent investors.  **[1610853_0001104659-25-089774_tm2526070d1_ex99-1.htm:0]** **[1610853_0001104659-25-089774_tm2526070d1_ex99-1.htm:2]** 
- The SOL treasury strategy will be guided by incoming Director and Executive Chairman **Joseph Chee**, Board Observer **Cosmo Jiang**, and Strategic Advisor **Dan Morehead**.  **[1610853_0001104659-25-089774_tm2526070d1_ex99-1.htm:0]**  
- HSDT, previously a medical device company with **$0.0 million in revenue** for the quarter ending June 30, 2025, is placing its legacy intellectual property under strategic review.

Helius Medical Technologies Announces Over $500 Million Funding for SOL Treasury Company

- **Helius Medical Technologies** is launching a **$500 million Solana-focused corporate treasury reserve**, with the potential to expand to over **$1.25 billion** through a private investment in public equity (PIPE) offering.  **[1610853_8b8ba0eaaaee4de68c815d33c888d73f]**  The PIPE offering stock was priced at **$6.88 per share** with warrants exercisable at **$10.12**.  **[1610853_8b8ba0eaaaee4de68c815d33c888d73f]** 
- The company plans to use the proceeds to acquire **Solana's native token (SOL)** and generate yield through **staking, lending, and decentralized finance opportunities** within the Solana ecosystem.  **[1610853_8b8ba0eaaaee4de68c815d33c888d73f]** 
- The financing round was led by **Pantera Capital and Summer Capital**, with participation from notable investors including **Animoca Brands and HashKey Capital**.  **[1610853_8b8ba0eaaaee4de68c815d33c888d73f]** 
- **Joseph Chee** has been appointed as incoming executive chairman to lead the firm's digital asset strategy.  **[1610853_8b8ba0eaaaee4de68c815d33c888d73f]** 
- Despite this strategic pivot, analysts maintain a **cautious outlook on Helius stock** due to the company's financial challenges, negative earnings, and bearish technical indicators.  **[1610853_8b8ba0eaaaee4de68c815d33c888d73f]**

Helius Medical Technologies Launches Solana-Backed Treasury Strategy

- Helius Medical Technologies (HSDT) announced the pricing of an oversubscribed private investment in public equity (PIPE) offering, expected to close around **September 18, 2025**.  **[1610853_20250915SF73263:0]** **[1610853_20250915SF73263:1]** 
- The offering is expected to generate **over $500 million** in proceeds from common stock and/or pre-funded warrants, with an additional **over $750 million** from stapled warrants, potentially unlocking **over $1.25 billion** in total.  **[1610853_20250915SF73263:0]** **[1610853_20250915SF73263:1]** 
- The net proceeds will be used to implement a digital asset treasury strategy, primarily to acquire **SOL**, the native cryptocurrency of the Solana blockchain, as the Company's main treasury reserve asset.  **[1610853_20250915SF73263:0]** **[1610853_20250915SF73263:1]** 
- The offering was led by **Pantera Capital** and **Summer Capital**, with participation from other prominent investors, and the SOL treasury strategy will be led by Joseph Chee, Cosmo Jiang, and Dan Morehead.  **[1610853_20250915SF73263:0]**

Solana (HSDT)